Search clinical trials for: Placebo toxin

Total 54709 results

Region Zealand

Recruiting

Botulinum Toxin for Chronic Neuropathic Pain

Chronic Pain | Neuralgia

Denmark
Cairo University

Not yet recruiting

Effect of Botox Injection in Anterior Belly of Digastric on Skeletal Relapse Following Mandibular Advancement Surgery

Orthognathic Relapse
University Hospital, Brest

Recruiting

Effectiveness and Safety of Early Intramuscular Botulinum Toxin Injections to Prevent Shoulder Deformity in Babies With Obstetrical Brachial Plexus Palsy (POPB-TOX)

Obstetrical Brachial Plexus Palsy

France
Qilu Hospital of Shandong University

Active, not recruiting

Effectiveness of Botulinum Toxin A in Preventing Scar Formation and Initial Exploration of "Optimal Concentration"

Scar

China
Assistance Publique - Hôpitaux de Paris

Completed

Intra-muscular Botulinum Toxin A in Chronic Athletic Pubalgia (PUBATOX)

Athletic Pubalgia

France
Columbia University

Completed

Effect of Dysport Injections on Energy Expenditure and Walking Efficiency in Children With Cerebral Palsy

Cerebral Palsy

United States
The University of Texas Health Science Center,...

Completed

Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip Repair

Cleft Palate | Cleft Lip | Scarring

United States
Izmir Katip Celebi University

Completed

Muscle Selection for Botulinum Toxin A Injection in Poststroke Elbow Flexor Spasticity

Muscle Spasticity

Turkey
Allergan

Completed

Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC)

Urinary Bladder, Overactive

United States
Allergan

Completed

BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity

Stroke | Cerebral Palsy | Muscle Spasticity | Pediatrics

United States, Korea, Republic of, Thailand, Hungary, Philippines, Poland, Russian Federation, Canada, Turkey
Daewoong Pharmaceutical Co. LTD.

Completed

Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm

Blepharospasm

Korea, Republic of
Allergan

Completed

Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines

Glabellar Rhytides

China
Allergan

Completed

BOTOX® Prophylaxis in Patients With Chronic Migraine

Migraine Disorders

United Kingdom, Sweden, Germany, Spain
Nigar Dursun

Completed

Safety on Switching Between Different Botulinum Toxin-A

Cerebral Palsy

Turkey
Allergan

Withdrawn

Open Label Study of BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Patients With Chronic Migraine

Migraine Disorders
Allergan

Completed

A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine

Migraine Disorders

United States, Australia, Korea, Republic of
Allergan

Completed

Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea

Urinary Bladder, Overactive | Urinary Incontinence

Korea, Republic of
Norwegian University of Science and Technology
St. Olavs Hospital

Completed

Botox Injection in Treatment of Chronic Migraine

Migraine Disorders

Norway
Allergan

Completed

An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder (GRACE)

Urinary Bladder, Overactive | Urinary Incontinence

United Kingdom, Germany, Spain, Sweden
University of Minnesota
Allergan

Completed

Use of Botulinum Toxin to Treat Psoriasis

Psoriasis Vulgaris

United States
Biolab Sanus Farmaceutica

Completed

Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face (XEO-001/07)

Skin Aging

Brazil
Allergan

Completed

A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic Migraines

Chronic Migraine, Headaches

United States
Allergan

Withdrawn

Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity

Stroke | Muscle Spasticity
Catholic University of the Sacred Heart

Completed

Intraprostatic Botulinum Toxin Type "A" Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy

Benign Prostatic Hyperplasia (BPH) | Benign Prostatic Enlargement (BPE)

Italy
Allergan

Completed

Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function

Stroke | Motor Neuron Disease | Muscle Spasticity

Poland, United States, Czech Republic, Hungary
Allergan

Completed

Effect of Botulinum Toxin Type A on Swallowing in Patients With Cervical Dystonia

Torticollis

Croatia
University of British Columbia
Allergan

Completed

Treatment of Thoracic Outlet Syndrome (TOS) With Botox

Thoracic Outlet Syndrome

Canada
Sunnybrook Health Sciences Centre
ethica Clinical Research Inc.

Completed

Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity

Neurogenic Detrusor Overactivity

Canada
Allergan

Completed

A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

Hyperhidrosis

United States, Sweden, United Kingdom, Germany
Chinese University of Hong Kong
New World Development Company Limited

Completed

Treatment of Tennis Elbow With Botulinum Toxin

Epicondylitis, Lateral Humeral

Hong Kong
Supernus Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects (MYSTICOL)

Sialorrhea

United States, Ukraine, Russian Federation
University Hospital, Toulouse

Completed

Evaluation of the Improvement of Quality of Life of Patients Suffering From Hailey Hailey or Darier Disease After Injections of Botulism Toxin Into Large Folds. (ToxHD)

Darier Disease | Hailey-Hailey Disease
Merz Pharmaceuticals GmbH

Completed

NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines (Head2Head)

Glabellar Frown Lines

United Kingdom, Germany, Austria
Supernus Pharmaceuticals, Inc.
Solstice Neurosciences

Active, not recruiting

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity

Spasticity

United States, Czechia
Merz Pharmaceuticals GmbH

Recruiting

Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury (PATTERN)

Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury

United States, Belgium, Czechia, France, Germany, Italy, Poland, Spain, United Kingdom, Australia, Hungary, Norway, Switzerland, Slovakia, Ukraine, Russian Federation
Ipsen

Terminated

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1 (CONTENT1)

Overactive Bladder | Urinary Incontinence

United States, Korea, Republic of, Czechia, Netherlands, Romania, Poland, Turkey, Portugal, Canada, Italy
Ipsen

Terminated

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2 (CONTENT2)

Overactive Bladder | Urinary Incontinence

Spain, Israel, Russian Federation, France, Germany, Australia, Belgium, Brazil, United Kingdom, Mexico, Colombia, Chile, Argentina, Lithuania, Peru, Ukraine
Merz Pharmaceuticals GmbH

Completed

Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability (SIPEXI)

Stroke | Cerebral Palsy | Intellectual Disability | Traumatic Brain Injury | Chronic Troublesome Sialorrhea

Georgia, Hungary, Poland, Russian Federation, Serbia, Ukraine
Ipsen

Completed

Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia

Cervical Dystonia

Germany, Austria
Ipsen

Completed

Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC) (ENGAGE)

Spastic Hemiparesis

United States, Russian Federation, Czechia, France
Ipsen

Completed

Dysport® Adult Upper Limb Spasticity Extension Study

Nervous System Disorders

United States, France, Belgium, Hungary, Poland, Italy, Czechia, Russian Federation, Slovakia
Ipsen

Terminated

Comparing Lower-concentration Dysport Treatment Targeted to the Neuromuscular Junction With Current Clinical Practice (NMJ)

Arm Spasticity

Sweden, Norway, Denmark, Finland
Eirion Therapeutics Inc.

Completed

ET-01 in Subjects With Lateral Canthal Lines, LCL-209

Crow's Feet | Lateral Canthal Lines, LCL

United States
Cairo University

Completed

The Effect of Botulinum Toxin A In Patients With Excessive Gingival Display With And Without Zinc Supplementation

Excessive Gingival Display

Egypt
Northwestern University

Completed

Botox and Suction-Curettage for Treatment of Excessive Underarm Sweating (Axillary Hyperhidrosis)

Axillary Hyperhidrosis

United States
Allergan

Completed

BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence

Masseter Muscle Prominence

United States
Revance Therapeutics, Inc.

Completed

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Lateral Canthal Lines

United States
Ipsen

Completed

Efficacy Study of Dysport® in the Treatment of Anal Fissure.

Anal Fissure

Czechia, Poland, Romania, Tunisia
Ipsen

Completed

Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial Spasm

Hemifacial Spasm

China
Prof. Dr. Volker Viereck

Completed

Mixed Urinary Incontinence Symptoms Before and After Treatment With Botox and Bulkamid

Mixed Incontinence, Urge and Stress

Switzerland

3

Subscribe